Faculty

Dr. Vera Combs Campbell Dr. Vera Combs Campbell Associate Professor and Assistant Dean for Assessment, School of Pharmacy Location:Flemmie Kittrell Hall213 Phone:757-727-6685 Expertise:Pharmacology, Toxicology, Assessment

Education

  • Bachelor of Arts in Biology, Hampton University, 1995
  • Doctor of Philosophy in Pharmacology and Toxicology, Virginia Commonwealth University (MCV campus), 2000
  • Higher Education Assessment Specialist Graduate Certificate Program, James Madison University, December, 2013

Post-Doctoral Experience

  • Post-Doctoral position at Howard University College of Medicine, Department of Pharmacology, 2003
  • Post-Doctoral position at the National Institute on Drug Abuse, Medications Discovery Research Branch, Psychobiology Section, 2000

Academic Appointments

  • 2012 - present, Assistant Dean for Assessment, School of Pharmacy
  • 2016 - present, Associate Professor of Pharmaceutical Sciences
  • 2005 - 2016, Assistant Professor of Pharmaceutical Sciences

Professional Associations

  • American Association of Colleges of Pharmacy (AACP)
  • American Society for Pharmacology and Experimental Therapeutics (ASPET)
  • Research Society on Alcoholism (RSA)
  • Society for Neuroscience (SfN)
  • Virginia Academy of Sciences (VAS)

Dr. Vera C. Campbell joined the faculty at the Hampton University School of Pharmacy in 2005 as an Assistant Professor in the Department of Pharmaceutical Sciences. As Assistant Professor, Dr. Campbell serves or has served as Chair of the following committees: Assessment; Curriculum; Scholarship, Awards, and Commencement; White Coat/Professional Awareness and Interview Days; and Academic Technology and Web. She is also the Chair of the University Program Review Committee and a member of the University TracDat Oversight Committee and Task Force Two: Academic Programs Committee. In 2012, she was promoted to Assistant Dean for Assessment. As Assistant Dean, she serves as Chair of the Assessment Committee; implements innovative methodologies for assessment of student learning outcomes; provides oversight for all programmatic and curricular assessment; oversees the implementation of the School's evaluation plan; and establishes and maintains a culture of assessment in the School.

Dr. Campbell has taught and coordinated several courses, Biology I (BIO 101), Anatomy and Applied Physiology (PHA 321), Pharmaceutical Care I (PHA 301), Pharmaceutical Care III (PHA 401), Drug and Disease State Management II (PHA 482), and Drug and Disease State Management VIII (PHA 588). Dr. Campbell's research interest is in the area of drug abuse and she has a keen interest in the co-abuse of alcohol and nicotine as well as opioid analgesics. Based on her research interest, she developed and teaches an elective course, Drugs of Abuse (PHA 582). Dr. Campbell is also interested in researching ways to improve student learning. In 2012, she was awarded a Hampton University Research Grant entitled, "Using a Calculations Reinforcement Approach to Improve NAPLEX Area 2 Sub-Scores in Pharmacy Students." Dr. Campbell hopes to improve the ability of pharmacy students to perform pharmaceutical calculations with this grant. Her research is published in peer reviewed journals and she has presented at national and international scientific meetings.

Grantsmanship

Ongoing Research Support

Using a Calculations Reinforcement Approach to Improve NAPLEX Area 2 Sub-Scores in Pharmacy Students

Faculty Development Grant, Hampton University
Role: Principal-Investigator Amount: $4,900

Completed Research Support

Tobacco Use Behaviors, Attitudes and Knowledge Among Educated Black Adults: The Efficacy of a Brief Tobacco Education Intervention

Faculty Development Grant, Hampton University
Role: Co-Investigator Amount: $4,800

Enhancing the Knowledge of Pharmacology in Scientific Research and Classrooms

Faculty Development Grant, Howard University
Role: Principal Investigator Amount: $4,000

Publications

  1. Campbell, V.C., Noreddin, A.N., Ombengi, D., Harris, W.T., Andrews, E., Ndemo, F., Azad, N., Iyer, A., Ramaley, C., Johnson, D.J., Richards-Spruill, P.L., Saulsbury, M. (2013) Calculations Across the Curriculum: An Innovative Approach to Improve Student's Ability to Perform Pharmaceutical Calculations. Am. J. Pharm. Educ.: Volume 77, Issue 5, Article 109.
  2. Campbell, V.C., Azad. A., Sampson, C.N., Richards-Spruill, P.L., Ndemo, F., Grant, S., Jones, L. (2013) A Predictive Validity Study of the HUSOP Preadmission Test on First Professional Year Pharmacy Courses. Am. J. Pharm. Educ.: Volume 77, Issue 5, Article 109.
  3. Campbell, V.C., Taylor, R.E., and Tizabi, Y. (2007) Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception. Alcohol Clin. Exp. Res. 31: 1435-1440.
  4. Campbell, V.C., Taylor, R.E., and Tizabi, Y. (2006) Antinociceptive effects of alcohol and nicotine in a rat model: Involvement of the opioid system. Brain Res. 1097: 71-77.
  5. Campbell, V.C., Kopajtic T.A., Newman A.H., and Katz J.L. (2005) Assessment of the influence of histaminergic actions on cocaine-like effects of 3a-diphenylmethoxytropane analogues J. Pharmacol. Exp. Ther. 315: 631-640.
  6. Campbell, V.C., Taylor R.E., and Tizabi Y. (2005) Antinociceptive effects of alcohol and nicotine in a rat model: involvement of the opioid system. Alc. Clin. Exp. Res. Supp 29: 14A. abstract
  7. Campbell, V.C. and Welch, S.P. (2001) The role of minoxidil on endogenous opioid peptides in the spinal cord: A putative co-agonist relationship between K-ATP openers and opioids. Eur. J. Pharmacol. 417: 91-98.
  8. Campbell, V.C., Dewey, W., and Welch, S.P. (2000) A comparison of 3H-Glyburide binding on morphine analgesia, tolerance, and dependence in ICR and Swiss Webster mice. J. Pharmacol. Exp. Ther. 295: 1112-1119.
  9. Pugh, G., Mason, D.J., Combs, V., and Welch, S.P. (1997) Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord. J. Pharmacol. Exp. Ther. 281: 730-737.

Presentations

  1. Campbell, V.C., Noreddin, A.N., Ombengi, D., Harris, W.T., Andrews, E., Ndemo, F., Azad, N., Iyer, A., Ramaley, C., Johnson, D.J., Richards-Spruill, P.L., Saulsbury, M. (2013) Calculations Across the Curriculum: An Innovative Approach to Improve Student's Ability to Perform Pharmaceutical Calculations. American Association of Colleges of Pharmacy, Chicago, IL.
  2. Campbell, V.C., Azad. A., Sampson, C.N., Richards-Spruill, P.L., Ndemo, F., Grant, S., Jones, L. (2013) A Predictive Validity Study of the HUSOP Preadmission Test on First Professional Year Pharmacy Courses. American Association of Colleges of Pharmacy, Chicago, IL.
  3. Hamilton B.S., Campbell V.C. and Ramaley C.C. (2010) Calculations Across the Curriculum (CAC): A Model of Cross Curricular Learning. Submitted and presented at 17th National HBCU Faculty Development Symposium, New Orleans, LA.
  4. Ramaley, C.C., Ramsinghani, S., Phillips, S.E., Morris, A.B., Campbell, V.C., Fisher, D.R., Javier, J.G., Martin, T.S., Morris, S.M., Morse, J.K., Ndemo, F.A, and McLean, H.M. (2007) One Year and Three Year Postgraduation Alumni Surveys: An Assessment Tool in Pharm.D. Programs. Indiana University-Purdue University Indianapolis Assessment Institute, Indianapolis, IN.
  5. Ramaley, C.C., Ndemo, F.A., Martin, T.S., Campbell, V.C. , Ramsinghani, S., Ogunbadeniyi, A.M., and McLean, H.M. (2007) Curriculum matrices: a useful tool for defining and measuring curricular outcomes. American Association of Colleges of Pharmacy, Orlando, FL.
  6. Campbell, V.C., Taylor, R.E., and Tizabi, Y. (2006) Selective opioid receptor antagonists attenuate the antinociceptive effects of alcohol and nicotine in a rat model. Research Society on Alcoholism, Baltimore, MD.
  7. Campbell, V.C., Taylor R.E., and Tizabi Y. (2005) Antinociceptive effects of alcohol and nicotine in a rat model: Involvement of the delta opioid system. Presented at the Society for Neuroscience, poster.
  8. Campbell, V.C., Kopajtic, A.H., and Katz, J.L. (2002) Evaluation of interactions between histamine H1 antagonist and cocaine effects as a mechanism for the decreased cocaine-like effects of benztropine analogs. Presented at the Society for Neuroscience, poster.
  9. Campbell, V.C., Dewey, W., and Welch, S.P. (1999) Interaction between opioids and K-ATP openers. Included in the proceedings at the annual conference on the College on Problems in Drug Dependence, oral presentation.
  10. Campbell, V.C., Dewey, W., and Welch, S.P. (1999) Role of ATP-gated potassium channels in morphine tolerance and dependence. Included in the proceedings at the annual conference Federation of American Societies for Experimental Biology, abstract.
  11. Campbell, V.C., Dewey, W., and Welch, S.P. (1998) Role of ATP-gated potassium channels in morphine tolerance and withdrawal. Included in the proceedings at the annual conference on the College on Problems in Drug Dependence, poster.
  12. Campbell, V.C., Dewey, W., and Welch, S.P. (1998) The effect of ATP-gated potassium channels in morphine tolerance and dependence. Presented at the Virginia Academy of Science, oral presentation.
  13. Campbell, V.C. and Welch, S.P. (1997) Modulation of ATP-Gated K+ Channels Following Morphine Tolerance and Dependence. Presented at the Virginia Academy of Science, oral presentation.